Tweyongyere Robert, Mawa Patrice A, Ngom-Wegi Sophy, Ndibazza Juliet, Duong Trinh, Vennervald Birgitte J, Dunne David W, Katunguka-Rwakishaya Eli, Elliott Alison M
Medical Research Council/Uganda Virus Research-Institute Uganda Research Unit on AIDS, Entebbe, Uganda.
J Infect Dis. 2008 Dec 15;198(12):1870-9. doi: 10.1086/593215.
Praziquantel treatment of schistosomiasis boosts antischistosome responses, with type 2 helper T cell bias that may contribute to immunologically mediated killing and to protection against reinfection. Praziquantel treatment during pregnancy was recommended in 2002, but the immunological effects of the treatment had not been investigated.
A cohort of 387 Schistosoma mansoni-infected women were recruited from a larger trial of deworming during pregnancy. Women were randomized to receive either praziquantel or placebo during pregnancy. Six weeks after delivery, all women received praziquantel. Cytokine responses to S. mansoni worm and egg antigens were measured in whole blood culture before and 6 weeks after each treatment.
Schistosome-specific cytokine responses were suppressed during pregnancy. Praziquantel treatment during pregnancy caused significant boosts in interferon-gamma (IFN-gamma), interleukin (IL)-2, IL-4, IL-5, IL-13, and IL-10 responses to schistosome worm antigen and in IFN-gamma, IL-5, and IL-13 responses to schistosome egg antigen, but these boosts were not as substantial as those seen for women treated after delivery.
Pregnancy suppresses a potentially beneficial boost in cytokine responses associated with praziquantel treatment. Further studies are needed on the long-term effects that treatment of schistosomiasis during pregnancy have on morbidity and resistance to reinfection among treated women and their offspring.
吡喹酮治疗血吸虫病可增强抗血吸虫反应,伴有2型辅助性T细胞偏向,这可能有助于免疫介导的杀伤作用以及预防再感染。2002年推荐在孕期使用吡喹酮治疗,但该治疗的免疫学效应尚未得到研究。
从一项更大规模的孕期驱虫试验中招募了387名感染曼氏血吸虫的女性。这些女性被随机分为在孕期接受吡喹酮或安慰剂治疗。分娩后六周,所有女性均接受吡喹酮治疗。在每次治疗前及治疗后6周,于全血培养中测量对曼氏血吸虫虫体和虫卵抗原的细胞因子反应。
孕期血吸虫特异性细胞因子反应受到抑制。孕期接受吡喹酮治疗使对血吸虫虫体抗原的干扰素-γ(IFN-γ)、白细胞介素(IL)-2、IL-4、IL-5、IL-13和IL-10反应以及对血吸虫虫卵抗原的IFN-γ、IL-5和IL-13反应显著增强,但这些增强程度不如产后接受治疗的女性明显。
孕期会抑制与吡喹酮治疗相关的细胞因子反应的潜在有益增强。需要进一步研究孕期治疗血吸虫病对接受治疗的女性及其后代的发病率和再感染抵抗力的长期影响。